Laurel Kelsey Alyssa Henderson, DDS
Oral Surgery · Boston
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Trustees of Boston University · 43 clinicians in this group
Looking this up.
Hospitals listed: Boston Medical Center Corporation-. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Henderson’s office at (617) 638-4350 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Boston Medical CenterBoston, MAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Boston Medical CenterPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.9 (3.89 to 7.9) · 1,382 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.56, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.569, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.437, Oct 2024 – Sep 2025
See every measure and the patient survey for Boston Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.9 (3.89 to 7.9) · 1,382 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.56 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.569 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.437 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 985 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.6 (135.51 to 215.7) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 81 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 332 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 204 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 367 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,737 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.05 to 0.44) · 5,544 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.12 to 0.5) · 5,662 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.69 (0.16 to 3.23) · 523 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.44 to 4.25) · 1,385 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.49 (2.58 to 14.41) · 497 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.46 to 8.12) · 529 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.86 (0.26 to 1.45) · 5,062 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 151 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.435 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.603 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 136 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 791 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 49.1 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.6 · 411 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 41.3 · 199 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 441 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.8 to 8.1) · 187 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (8.8 to 15.4) · 187 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.9 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (11 to 18.5) · 987 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 399 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,808 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Drugs they prescribed that Part D paid
$15,644
Pharmacies billed $15,644 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
379 generic and fewer than 11 brand-name prescriptions · $15,644 in drug cost · 21 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pilocarpine | 50 | $4,572 | $91 |
| Cevimeline | 22 | $3,415 | $155 |
| Dexamethasone | 51 | $1,258 | $25 |
| Tacrolimus | 12 | $1,102 | $92 |
| Nystatin | 28 | $672 | $24 |
See all 11 drugs
| Pilocarpine | 50 | $4,572 | $91 |
| Cevimeline | 22 | $3,415 | $155 |
| Dexamethasone | 51 | $1,258 | $25 |
| Tacrolimus | 12 | $1,102 | $92 |
| Nystatin | 28 | $672 | $24 |
| Gabapentin | 24 | $432 | $18 |
| Clobetasol Propionate | 11 | $388 | $35 |
| Amoxicillin-Clavulanate Potass | 11 | $337 | $31 |
| Fluconazole | 31 | $298 | $10 |
| Chlorhexidine Gluconate | 52 | $269 | $5 |
| Clonazepam | 11 | $115 | $10 |
Year by year
| 2024 | 393 | 140 | None | None | $15,644 |
| 2023 | 329 | 137 | None | None | $13,146 |
| 2022 | 112 | 60 | 0% (0) | None | $4,544 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Pilocarpine | 35 | $2,659 | $76 |
| Dexamethasone | 28 | $1,157 | $41 |
| Nystatin | 38 | $934 | $25 |
| Clobetasol Propionate | 16 | $743 | $46 |
| Amoxicillin-Clavulanate Potass | 19 | $425 | $22 |
| Chlorhexidine Gluconate | 64 | $423 | $7 |
| Fluconazole | 22 | $366 | $17 |
| Cyclobenzaprine | 12 | $102 | $9 |
2022: 3 drugs
| Nystatin | 25 | $555 | $22 |
| Gabapentin | 11 | $305 | $28 |
| Dexamethasone | 11 | $205 | $19 |
Professional record
- NPI
- 1205309648
- Trained
- University of South Carolina School of Medicine, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 122300000X (122300000X); Federal specialty code 1223X2210X (1223X2210X); Federal specialty code 125Q00000X (125Q00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2019-01-08
- NPI last updated
- 2026-09-02
- NPI record certified
- 2026-09-02
This is when the NPI record was last certified, not a medical board exam.